HOME >> MEDICINE >> NEWS
GSK announces launch of largest ever Phase III trial in lung cancer treatment

II NSCLC Clinical Trial Results:

This Phase II double-blind, placebo-controlled study is the first proof-of-concept trial for an ASCI in early NSCLC. The study randomized 182 patients with completely resected stage IB or II NSCLC to receive either MAGE-A3 ASCI or placebo as adjuvant therapy. All patients participating in the trial had cancers expressing a tumor-specific antigen known as MAGE-A3, which is present in approximately 35 percent to 50 percent of early NSCLC.1

The final analysis was performed at a median follow-up of 28 months. At this time, 41 of the 122 patients receiving MAGE-A3 relapsed (30.6%); in comparison to 26 of the 60 patients receiving placebo (43.3%). Using a Cox regression model to adjust for the fact that patients in the different arms were enrolled in the study at different times, there was a 27% reduction in the relative risk of cancer recurrence following surgery, compared with placebo (p=0.107). Although the study was not powered to show statistical significance, the trend is encouraging and warrants continued clinical investigation of MAGE-A3 ASCI.

In the Phase II clinical study, the most commonly reported adverse events were mild local (pain, redness, swelling) or systemic (fever, fatigue, muscle pain) reactions observed within the 24 hours of injection. Out of 182 patients, one patient was withdrawn from the clinical trial due to adverse events possibly related to the MAGE-A3 treatment. Based on available results, GSKs MAGE-A3 ASCI may have the potential to be suitable for maintenance therapy delivered intra-muscularly on an outpatient basis.

Phase III Non-Small Cell Lung Cancer Trial Launch:

GSK is now recruiting for a Phase III trial evaluating MAGE-A3 ASCI as adjuvant therapy in MAGE-A3 positive patients with NSCLC. With a target of about 2,270 patients, the randomized, double-blind, and placebo-controlled MAGRIT trial (MAGE-A3 as Adjuvant Non-Small Cell Lung Cancer Immu
'"/>

Contact: Andrea Long
andreal@wagged.com
202-326-0791
GlaxoSmithKline Biologicals
5-Jun-2007


Page: 1 2 3

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. AstraZeneca announces SYMBICORT is now available in the US
3. Weill Cornell Medical College announces gifts totaling $400M
4. Elsevier announces launch of Brain Stimulation
5. NSW Premier announces $15M for childrens cancer research
6. National Inventors Hall of Fame announces 2007 inductees
7. Emory University announces new Global Health Institute
8. BioMed Central announces Journal of Medical Case Reports
9. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
10. Wiley announces partnership with NASPGHAN and AASLD
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/15/2019)... ... ... An October 3 article on CNN Health explains why people ... that both agents are mildly abrasive; so while they may be good at removing ... are also good at stripping the enamel off of teeth if used often. This ...
(Date:10/15/2019)... ... October 15, 2019 , ... Nashville Fertility Center (NFC) is proud to ... to join the practice. In addition to treating general infertility, Dr. Van Heertum offers ... at NFC looks forward to Dr. Van Heertum joining the practice and believes she ...
(Date:10/10/2019)... ... , ... AltMed Florida , one of the fastest growing Medical Marijuana ... opening of its second MÜV™ Medical Cannabis Dispensary on the First Coast – scheduled ... Beach. , Located at Beach Plaza Shopping Center at the corner of Beach Boulevard ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Ralphs, QFC and Fred Meyer, King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , ... grain-free & gluten-free. , “Ingredient purity and fresh taste is paramount for ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley Smile Solutions ... relief from this common and treatable condition. Dr. HagShenas’ goal is to treat ... with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum disease from ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... MONTREAL (PRWEB) , ... October 18, 2019 , ... It ... a mental component designed to keep athletes “in the zone” in order to deliver ... could measure the effect negative thoughts and emotions have on an athlete’s physiology, then ...
(Date:10/17/2019)... YORK (PRWEB) , ... October 17, 2019 , ... One of the most prominent features ... that are overly large or they stick out too far from the skull. This can ... look for a way to alter and reduce the appearance of their ears. In order ...
(Date:10/15/2019)... ... , ... An Alabama jury has returned a $9 million verdict for the ... for Lee County. , In December of 2014, Hope Johnson visited Auburn Urgent Care ... two days earlier with similar, but milder complaints. On that first visit, she was ...
Breaking Medicine Technology:
Cached News: